HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Detection of rViscumin in plasma samples by immuno-PCR.

Abstract
To allow for pharmacokinetic studies in adjunction with the current clinical developments of the potent cytostatic anti-cancer drug rViscumin, a sandwich immuno-PCR (IPCR) assay was developed for the detection of rViscumin in blood plasma. The IPCR was carried out with a commercially available reagent kit, consisting of pre-assembled rViscumin-specific antibody-DNA conjugates as well as a specific competitor DNA fragment to be amplified by PCR. Various combinations of capture- and detection-antibodies were compared for performance in IPCR. Using the optimized assay, as few as 50 zeptomol (approx. 100 fg/ml) rViscumin (MW 57 kDa) was detectable in standardized human serum samples. The IPCR assay was very selective for rViscumin and in spiking experiments in proband plasma samples, signal recovery rates between 70% and 120% were obtained. The linear sensitivity range of the assay covered more than five orders of magnitude. Repeated measurements of rViscumin resulted in a mean standard deviation value of 14.2%.
AuthorsMichael Adler, Martin Langer, Klaus Witthohn, Jürgen Eck, Dietmar Blohm, Christof M Niemeyer
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 300 Issue 3 Pg. 757-63 (Jan 17 2003) ISSN: 0006-291X [Print] United States
PMID12507515 (Publication Type: Comparative Study, Evaluation Study, Journal Article)
Chemical References
  • Plant Lectins
  • Plant Preparations
  • Plant Proteins
  • Ribosome Inactivating Proteins, Type 2
  • Toxins, Biological
  • ribosome inactivating protein, Viscum
Topics
  • Animals
  • Antibody Specificity
  • Cross Reactions (immunology)
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • Plant Lectins (blood, genetics, immunology)
  • Plant Preparations (blood, immunology)
  • Plant Proteins
  • Polymerase Chain Reaction (methods, standards)
  • Reproducibility of Results
  • Ribosome Inactivating Proteins, Type 2
  • Sensitivity and Specificity
  • Toxins, Biological (blood, genetics, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: